• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAL(RH48)血型抗原:血清学观察

JAL (RH48) blood group antigen: serologic observations.

作者信息

Lomas-Francis Christine, Alcantara Denden, Westhoff Connie, Uehlinger Joan, Valvasori Marilia, Castilho Lillian, Reid Marion E

机构信息

Laboratory of Immunohematology, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA.

出版信息

Transfusion. 2009 Apr;49(4):719-24. doi: 10.1111/j.1537-2995.2008.02025.x. Epub 2008 Dec 15.

DOI:10.1111/j.1537-2995.2008.02025.x
PMID:19192256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2756138/
Abstract

BACKGROUND

JAL (RH48) is a low-prevalence antigen in the Rh blood group system and anti-JAL has caused hemolytic disease of the newborn. JAL is associated with either a haplotype carrying depressed C and e antigens or one carrying depressed c and e antigens. Blood samples from JAL+ people were tested, published serologic findings were confirmed, serologic studies were extended to include expression of other Rh antigens, and the antibody specificities produced by three sensitized JAL+ probands are reported.

STUDY DESIGN AND METHODS

Red blood cell (RBC) samples from 17 (12 probands) JAL+ persons were tested by hemagglutination using standard methods.

RESULTS

RBCs from both the Caucasian JAL+ probands had the (C)(e) haplotype and weakened C, e, hr(B), and hr(S) antigens. JAL+ samples from black persons had the (c)(e) haplotype and expressed weakened c, e, f, V, VS, hr(B), and hr(S) antigens. Plasma from three sensitized c+e+ JAL+ probands contained alloanti-c, alloanti-e, or alloantibody of apparent anti-Rh17 specificity. This study shows that this alloanti-Rh17-like antibody recognizes the high-prevalence antigen antithetical to JAL that has been named CEST.

CONCLUSIONS

The presence of the JAL antigen has a quantitative (weakening) effect on the expression of C, e, hr(B), and hr(S) antigens in Caucasian persons and of c, e, f, V, VS, hr(B), and hr(S) antigens in people of black African ancestry. A qualitative effect also was demonstrated by the presence of alloanti-c or alloanti-e in the plasma of two transfused c+e+ patients and by an antibody (anti-CEST) that recognizes the high-prevalence antigen antithetical to JAL.

摘要

背景

JAL(RH48)是Rh血型系统中的一种低频率抗原,抗JAL可导致新生儿溶血病。JAL与携带减弱的C和e抗原的单倍型或携带减弱的c和e抗原的单倍型相关。对JAL阳性个体的血样进行了检测,证实了已发表的血清学研究结果,血清学研究扩展至包括其他Rh抗原的表达,并报告了三名致敏JAL阳性先证者产生的抗体特异性。

研究设计与方法

采用标准方法通过血凝试验检测了17名(12名先证者)JAL阳性个体的红细胞(RBC)样本。

结果

白种人JAL阳性先证者的红细胞均具有(C)(e)单倍型,且C、e、hr(B)和hr(S)抗原减弱。黑人的JAL阳性样本具有(c)(e)单倍型,且c、e、f、V、VS、hr(B)和hr(S)抗原表达减弱。三名致敏的c+e+JAL阳性先证者的血浆中含有同种抗-c、同种抗-e或具有明显抗Rh17特异性的同种抗体。本研究表明,这种类抗Rh17抗体识别与JAL相对的高频率抗原,该抗原已被命名为CEST。

结论

JAL抗原的存在对白种人中C、e、hr(B)和hr(S)抗原以及非洲黑人后裔中c、e、f、V、VS、hr(B)和hr(S)抗原的表达具有定量(减弱)作用。两名接受输血的c+e+患者血浆中存在同种抗-c或同种抗-e以及识别与JAL相对的高频率抗原的抗体(抗CEST)也证明了其定性作用。

相似文献

1
JAL (RH48) blood group antigen: serologic observations.JAL(RH48)血型抗原:血清学观察
Transfusion. 2009 Apr;49(4):719-24. doi: 10.1111/j.1537-2995.2008.02025.x. Epub 2008 Dec 15.
2
Molecular basis of the Rh antigen RH48 (JAL).Rh抗原RH48(JAL)的分子基础
Vox Sang. 2009 Apr;96(3):234-9. doi: 10.1111/j.1423-0410.2008.01142.x. Epub 2008 Dec 12.
3
Alloanti-c in a c-positive, JAL-positive patient.一名C阳性、JAL阳性患者体内的同种抗 - c。
Vox Sang. 2009 Apr;96(3):240-3. doi: 10.1111/j.1423-0410.2008.01135.x. Epub 2008 Dec 5.
4
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.JAL抗原(RH48)是由编码精氨酸114色氨酸的RHCE发生变化所致。
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
5
The red cell antigen JAL in the Swiss population: family studies showing that JAL is an Rh antigen (RH48).瑞士人群中的红细胞抗原JAL:家族研究表明JAL是一种Rh抗原(RH48)。
Vox Sang. 1990;59(1):44-7. doi: 10.1111/j.1423-0410.1990.tb02113.x.
6
RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance.黑人群体中 RHCE*ceMO 基因常与 RHD*DAU0 基因同型,且编码 hr(S)-、hr(B)-、RH:-61 表型:临床意义。
Transfusion. 2013 Nov;53(11 Suppl 2):2983-9. doi: 10.1111/trf.12271. Epub 2013 Jun 17.
7
Red cells from the original JAL+ proband are also DAK+ and STEM+.来自最初 JAL+先证者的红细胞也是 DAK+和 STEM+。
Vox Sang. 2011 Jul;101(1):61-4. doi: 10.1111/j.1423-0410.2010.01465.x. Epub 2011 Apr 8.
8
Kell Blood Group System凯尔血型系统
9
A case of fatal hemolytic disease of the newborn associated with-D-/-D-phenotype.一例与-D/-D表型相关的新生儿致命性溶血病。
Am J Perinatol. 1997 Sep;14(8):495-7. doi: 10.1055/s-2007-994188.
10
Alloanti-c (RH4) revealing that the (C)ce s haplotype encodes a partial c antigen.同种抗 -c(RH4)表明(C)ce单倍型编码一种部分c抗原。
Transfusion. 2009 Jul;49(7):1329-34. doi: 10.1111/j.1537-2995.2009.02129.x. Epub 2009 Mar 20.

引用本文的文献

1
Genotyping in Sickle Cell Disease Patients: The French Strategy.镰状细胞病患者的基因分型:法国的策略。
Transfus Med Hemother. 2018 Jul;45(4):264-270. doi: 10.1159/000490858. Epub 2018 Jul 6.
2
Mutation in Rh48: Assessment for possible mutation prone point.Rh48中的突变:对可能的突变易发位点的评估。
Indian J Hematol Blood Transfus. 2010 Mar;26(1):6-7. doi: 10.1007/s12288-010-0003-9. Epub 2010 Aug 4.
3
RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa.RHCE*ceTI 编码部分 c 和部分 e,并且通常与 RHD*DIVa 顺式排列。
Transfusion. 2013 Apr;53(4):741-6. doi: 10.1111/j.1537-2995.2012.03800.x. Epub 2012 Jul 13.
4
Red cells from the original JAL+ proband are also DAK+ and STEM+.来自最初 JAL+先证者的红细胞也是 DAK+和 STEM+。
Vox Sang. 2011 Jul;101(1):61-4. doi: 10.1111/j.1423-0410.2010.01465.x. Epub 2011 Apr 8.
5
RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford.RHCE*ceCF 编码部分 c 和部分 e,但不编码 CELO,后者是与 Crawford 抗原相对立的抗原。
Transfusion. 2011 Jan;51(1):25-31. doi: 10.1111/j.1537-2995.2010.02764.x.
6
A novel RHCE*ce 48C, 733G allele with Nucleotide 941C in Exon 7 encodes an altered red blood cell e antigen.一个新的 RHCE*ce 48C、733G 等位基因,其核苷酸 941C 位于 7 号外显子,编码一个改变的红细胞 e 抗原。
Transfusion. 2011 Jan;51(1):32-5. doi: 10.1111/j.1537-2995.2010.02765.x.
7
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.JAL抗原(RH48)是由编码精氨酸114色氨酸的RHCE发生变化所致。
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
8
Alloanti-c in a c-positive, JAL-positive patient.一名C阳性、JAL阳性患者体内的同种抗 - c。
Vox Sang. 2009 Apr;96(3):240-3. doi: 10.1111/j.1423-0410.2008.01135.x. Epub 2008 Dec 5.

本文引用的文献

1
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.JAL抗原(RH48)是由编码精氨酸114色氨酸的RHCE发生变化所致。
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
2
Alloanti-c in a c-positive, JAL-positive patient.一名C阳性、JAL阳性患者体内的同种抗 - c。
Vox Sang. 2009 Apr;96(3):240-3. doi: 10.1111/j.1423-0410.2008.01135.x. Epub 2008 Dec 5.
3
The structure and function of the Rh antigen complex.Rh抗原复合体的结构与功能。
Semin Hematol. 2007 Jan;44(1):42-50. doi: 10.1053/j.seminhematol.2006.09.010.
4
Molecular basis of the LOCR (Rh55) antigen.LOCR(Rh55)抗原的分子基础。
Transfusion. 2006 Oct;46(10):1689-92. doi: 10.1111/j.1537-2995.2006.00968.x.
5
A "NEW" RH ANTIBODY (ANTI-RH 26) WHICH DETECTS A FACTOR USUALLY ACCOMPANYING HR'.一种“新型”Rh抗体(抗-Rh 26),可检测到一种通常与HR'相伴的因子。
Transfusion. 1964 Nov-Dec;4:414-8. doi: 10.1111/j.1537-2995.1964.tb02900.x.
6
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.非洲加勒比裔黑人中的罕见RHCE血型表型:鉴定与输血安全性
Blood. 2002 Dec 1;100(12):4223-31. doi: 10.1182/blood-2002-01-0229. Epub 2002 Aug 1.
7
Involvement of Gly96 in the formation of the Rh26 epitope.
Transfusion. 1997 Nov-Dec;37(11-12):1123-30. doi: 10.1046/j.1537-2995.1997.37111298088040.x.
8
The red cell antigen JAL in the Swiss population: family studies showing that JAL is an Rh antigen (RH48).瑞士人群中的红细胞抗原JAL:家族研究表明JAL是一种Rh抗原(RH48)。
Vox Sang. 1990;59(1):44-7. doi: 10.1111/j.1423-0410.1990.tb02113.x.
9
A low-incidence red cell antigen JAL associated with two unusual Rh gene complexes.
Vox Sang. 1990;59(1):39-43. doi: 10.1111/j.1423-0410.1990.tb02112.x.